Clinical Trial Update: Immune Modulation by Misoprostol [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial evaluates how misoprostol modulates the immune response in gynecological infections. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecological Infection

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Vanderbilt University | Conditions: Gynecological Infection | EARLY_Phase 1 | Status: COMPLETED